Suchergebnisse - "Vališ, Martin"

PubPharm (245)

1

HIF-1α is a "brake" in JNK-mediated activation of amyloid protein precursor and hyperphosphorylation of tau induced by T-2 toxin in BV2 cells

enthalten in: Mycotoxin research | 2024

von Zhao, Y. | Valis, M. | Wang, X. | +3

2

Capillary zone electrophoresis method for quantification of therapeutic peptide glatiramer acetate

enthalten in: Monatshefte für Chemie | 2024

von Niaei, N. | Vališ, M. | Petr, J.

3

Inhibition of CD40L with Frexalimab in Multiple Sclerosis

enthalten in: The New England journal of medicine | 2024

von Vermersch, P. | Granziera, C. | Mao-Draayer, Y. | +51

4

HIF-1α is a “Brake” in JNK3 Mediated Activation of Amyloid Protein Precursor and Hyperphosphorylation of Tau Induced by T-2 Toxin in BV2 Cells

enthalten in: ResearchSquare.com | 2024

von Zhao, Y. | Valis, M. | Wang, X. | +3

5

Intravenous Thrombolysis in Posterior versus Anterior Circulation Stroke : Clinical Outcome Differs Only in Patients with Large Vessel Occlusion

enthalten in: Biomedicines | 2024

von Halúsková, S. | Herzig, R. | Mikulík, R. | +14

6

HIF-1α is a “brake” in JNK-mediated activation of amyloid protein precursor and hyperphosphorylation of tau induced by T-2 toxin in BV2 cells

enthalten in: Mycotoxin research | 2024

von Zhao, Y. | Valis, M. | Wang, X. | +3

7

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

enthalten in: Drugs in R&D | 2023

von Vališ, M. | Achiron, A. | Hartung, H. | +6

8

Pralidoxime-like reactivator with increased lipophilicity - Molecular modeling and in vitro study

enthalten in: Chemico-biological interactions | 2023

von Kuca, K. | Valle da Silva, J. | Nepovimova, E. | +5

9

Corrigendum to "The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease" [Biomed. Pharmacother. 159 (2023) 114223

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Valis, M. | Dlabkova, A. | Hort, J. | +6

ErratumFor: Biomed Pharmacother. 2023 Mar;159:114223. - PMID 36630846

10

Sepsis-mediated renal dysfunction : Pathophysiology, biomarkers and role of phytoconstituents in its management

enthalten in: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2023

von Balkrishna, A. | Sinha, S. | Kumar, A. | +6

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[25]